Studies have eluded to an increase in senescent CD4+ T cells in young patients with T2D 31 and CD8+ senescent cells in older adults with T2D 32, although in both papers cells were defined as being senescent using only the loss of the co‐stimulatory marker CD28. Here, CD28 is linked to type 2 diabetes mellitus.